ScopusElsevier Scopus
Status
Active
Coverage
2021–present
Source type
Journal
Open access
Yes
CiteScore
7.6
SJR · SCImago
1.504
Q1 SJR quartile
H-index
20
Best quartile
Q2 · 73rd pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology | 64 / 243 | 73rd | Q2 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Immunotherapy Advances
Immunotherapy Advances is Scopus-indexed (Q2, CiteScore 7.6), WoS ESCI, DOAJ. Published by Oxford University Press.
Checked against the index lists dated .
ISSN 2732-4303Verify ISSN ↗
Publisher: Oxford University Press
Scopus · Q2WoS · ESCIOpen Access
7.6
CiteScore 2025
Q2
Best quartile
3
Indexed in
Cost to publish: Checking DOAJ for article charges…
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
DOAJDirectory of Open Access Journals (live)
Listed in DOAJ
Open accessFully open access, peer reviewed
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Immunotherapy Advances indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q2, CiteScore 7.6.
What quartile is Immunotherapy Advances in Scopus?
Immunotherapy Advances is Q2 in Immunology (rank 64 of 243), by CiteScore 2025.
What is the impact factor of Immunotherapy Advances?
Immunotherapy Advances is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.6, which places it in quartile Q2 at the 73rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.504, quartile Q1, with an H-index of 20.
How much does it cost to publish in Immunotherapy Advances?
The publisher lists an article processing charge of about US$3,053 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Immunotherapy Advances and what is its ISSN?
Immunotherapy Advances is published by Oxford University Press. Its ISSN is 2732-4303.
Is Immunotherapy Advances in Web of Science?
Yes — indexed in the Emerging Sources Citation Index.
Is Immunotherapy Advances open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is Immunotherapy Advances? — open metrics via OpenAlex
Immunotherapy Advances has an h-index of 25 and a 2-year mean of 3.16 citations per paper (OpenAlex). Its Scopus CiteScore is 7.6, quartile Q2. On 2-year citations it ranks #90 of 240 Scopus journals in Immunology.
25
h-index
3.16
2-yr mean citations
57
i10-index
162
works indexed
1,848
total citations
Publication fee · open access list price, US$
US$3,053
2-yr mean citations, among Scopus journals in the same subject
#90 of 240 Top 38% Immunology
Immunotherapy Advances published 24 papers in 2025; its busiest recent year was 2024 with 42. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Immunotherapy Advances? — latest 100 articles, 2022–2026
In its latest 100 research articles (2022–2026), authors are most often from United Kingdom (38.6%), China (12.5%) and United States (8.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Immunotherapy Advances? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journals Journal Indexed in
In Silico Plants Scopus Q1 WoS ESCI DOAJ Industrial and Corporate Change Scopus Q1 WoS SSCI ABDC A ABS 3 Industrial Law Journal Scopus Q1 WoS SSCI ABDC A ABS 3 Inflammatory Bowel Diseases Scopus Q1 WoS SCIE Information and Inference Scopus Q1 WoS SCIE Innovation in Aging Scopus Q1 WoS SCIE/SSCI DOAJ Insect Systematics and Diversity Scopus Q1 WoS SCIE Integrated Environmental Assessment and Management Scopus Q1 WoS SCIE
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.